Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975.
暂无分享,去创建一个
G. Giaccone | A. Bottomley | E. Smit | F. Schramel | J. V. van Meerbeeck | C. Legrand | C. Debruyne | R. Gaafar | C. Coens | F. Efficace | C. Manegold | H. Smit | B. Biesma | P. Lianes | J. V. Meerbeeck
[1] D. Osoba,et al. Health-related quality of life in patients with glioblastoma: a randomised controlled trial. , 2005, The Lancet. Oncology.
[2] M. Parmar,et al. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] S. Barni,et al. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] K. Van Steen,et al. Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] J. Dancey,et al. Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial. , 2004, Lung cancer.
[6] F. Fang,et al. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy , 2004, Cancer.
[7] H. V. Gelder. The Netherlands , 2004, Constitutions of Europe (2 vols.).
[8] G. Giaccone,et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Paul Glare,et al. A systematic review of physicians' survival predictions in terminally ill cancer patients , 2003, BMJ : British Medical Journal.
[10] R. Labianca,et al. Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. , 2003, European journal of cancer.
[11] D. Cella,et al. Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] G. Molenberghs,et al. Multicollinearity in prognostic factor analyses using the EORTC QLQ‐C30: identification and impact on model selection , 2002, Statistics in medicine.
[13] A. Norman,et al. Baseline quality of life predicts survival in patients with advanced colorectal cancer. , 2002, European journal of cancer.
[14] Ali Montazeri,et al. Quality of life in lung cancer patients: as an important prognostic factor. , 2001, Lung cancer.
[15] N. Aaronson,et al. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] J. Holland,et al. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? , 1999, Cancer.
[17] L. Norton,et al. Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. , 1995, Journal of the National Cancer Institute.
[18] K R Hess,et al. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. , 1995, Statistics in medicine.
[19] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[20] J. Crowley,et al. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] K. Van Steen,et al. Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? , 2006, European journal of cancer.
[22] Taylor Murray,et al. Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.
[23] Andrew Bottomley,et al. EORTC QLQ-C30 Scoring Manual , 1995 .
[24] S. Kaasa,et al. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. , 1994, European journal of cancer.
[25] M Schumacher,et al. A bootstrap resampling procedure for model building: application to the Cox regression model. , 1992, Statistics in medicine.
[26] D.,et al. Regression Models and Life-Tables , 2022 .